HALOBETASOL PROPIONATE Recall D-0688-2022
Description: Halobetasol Propionate Ointment, 0.05%, Net Wt. 50 grams tube, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70809, NDC 70512-033-50.
HALOBETASOL PROPIONATE Recall D-0688-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0688-2022 |
Event ID | 89798 |
Brand | HALOBETASOL PROPIONATE |
Generic Name | HALOBETASOL PROPIONATE OINTMENT |
Manufacturer | HALOBETASOL PROPIONATE OINTMENT |
Original Package? | 1 |
Active Substance | HALOBETASOL PROPIONATE |
Drug Route | TOPICAL |
Distribution | Nationwide in the USA and Puerto Rico |
Quantity | 35,185 tubes |
Recall Reason | cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. |
Drug Classification | Class II |
Drug Code Info | 20220330 |
Product NDC | 70512-033 |
Drug UPC | 0370512033507 |
Recall Initiation Date | 20220315 |
Report Date | 20220330 |
Classification Date | 20220321 |
Address | 105 Lincoln Avenue Buena, NJ 08310 United States |
Recalling Firm | Teligent Pharma, Inc. |
Initial Notification | Letter |
Unique Ingredient Identifier | 91A0K1TY3Z |
Drug Application Number | ANDA209978 |
Structured Product Labeling (SPL ID) | b8b88fbe-73bf-52ef-e053-2995a90ae826 |
Structured Product Labeling (SPL Set ID) | 81ab198c-96ff-ce4b-e053-2a91aa0aaf61 |
Similar To |